The list of Canadian licensed producers (LPs) of cannabis expecting to go public just got longer. CanniMed Therapeutics, the parent of CanniMed Ltd. and Prairie Plant Systems, issued a press...
The Innovative Industrial Properties IPO, originally planned at $175mm, has been reduced to $100mm, according to the 4th amendment to the S-11 registration statement. The offering, which was originally...
The pending IPO of Innovative Industrial Properties (NYSE: IIPR), originally expected to price earlier this week, was delayed until at least next week. The company filed a third amendment...
One of the biggest stories in the cannabis industry this year has been the massive amount of capital raised by licensed producers in Canada. Already OrganiGram (TSXV: OGI) (OTC:...
Supreme Pharma (CSE: SL) (OTC: SPRWF) announced after the close that it will be issuing convertible notes and warrants in a “bought deal” underwritten by Canaccord Genuity. The $40mm...
Canadian licensed producer Aphria (TSXV: APH) (OTC: APHQF) announced a C$35mm capital raise this morning, marking the largest single offering by a public company in the cannabis industry to...
Publicly-traded Helix TCS (OTC: HLIX) announced the acquisition of shares of privately-held BioTrackTHC from founder Steven Siegel and co-founder Brian McClintock. The press release lacked details about the size of the stake,...
Innovative Industrial Properties, which had filed to go public last month, revised its S-11 registration today. The new filing indicated that the New York Stock Exchange (NYSE) has now approved the...
Hemp Business Journal (HBJ), the definitive source for market sizes and high-level analysis of business trends in the hemp industry, followed up its initial market research piece, The State of...
The publicly-traded cannabis stocks have enjoyed an immense rally that began on 9/1, fueled by speculation regarding this week’s legalization ballot initiatives in Arizona, California, Maine, Massachusetts and Nevada along with...
More than six months ahead of the May 6, 2017 deadline for adoption, the Ohio Department of Commerce has issued proposed rules for cultivators in the Ohio Medical Marijuana Control...
Cannabis stocks have rallied dramatically in the past two months, with the Cannabis Stock Index more than doubling from the end of August, rising 136% from 33.16 on 8/31 to...
On June 1, 2015, Governor Greg Abbott of Texas signed the state’s “Compassionate Use Program”, Senate Bill 339, into law. One of the most restrictive medical cannabis programs in the...
After what seems like an unacceptably long delay, Health Canada, which oversees the Canadian medical cannabis program, ACMPR, reported data for the quarter ending 06/30/16 on Friday. The number of patients enrolled in...
One of the most interesting panels at the recent New West Summit was a presentation by Dr. Jonathan Cachat of Fleurish Farms about new sunlight capture cultivation technology that Fleurish Farms...
I had the privilege of moderating a panel on publicly-traded cannabis stocks at the recent New West Summit in San Francisco. The goal of the discussion was to help...
The highly successful New West Summit in San Francisco this past weekend included a panel “Canada’s Cannabis Legalization” that I moderated with a goal of informing attendees about the opportunities...
Cannabis stocks are on fire. The last time I wrote about the cannabis stock rally, the index was just above 40, up 22.1% YTD through September 23rd. Today, less...
A veteran of the Health Care Real Estate Investor Trust (REIT), Alan Gold, has created what will soon be the first publicly-traded cannabis REIT, Innovative Industrial Properties. The company,...
Cannabis stocks have been on quite the tear, with the index almost doubling from the levels near the end of August as traders gravitate to the sector in front of...
Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) announced another capital raise today, engaging Canaccord Genuity to help it raise up to $25mm through a private placement of 10% convertible notes that...
Goldman Sachs initiated coverage on GW Pharma (NASDAQ: GWPH) (AIM: GWP) on October 7th, with a “Buy” rating and a target of $189. The target was based on blend...
Since 2007, Global Alpha Forum has been bringing together hundreds of Alternative Investment professionals, offering panels and one-on-one meetings with a goal of covering the current state of the...
Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) announced today that it accelerated the exercise of 5.77mm warrants, most of which were exercisable at $0.66, associated with a capital raise that...
There is little doubt that cannabidiol (CBD) has medicinal benefits. Sanjay Gupta brought this into the mainstream in 2013 with his famous reversal, and, three years later, GW Pharma (NASDAQ:...
